Armstrong J D, Harvey R W, Poore M A, Simpson R B, Miller D C, Gregory G M, Hartnell G F
Department of Animal Science, North Carolina State University, Raleigh 27695-7621, USA.
J Anim Sci. 1995 Oct;73(10):3051-61. doi: 10.2527/1995.73103051x.
In Exp. 1, Angus (A, n = 30), Charolais (C, n = 37), and Simmental (S, n = 30) multiparous cows received (s.c.) recombinantly derived bovine somatotropin (bST; sometribove, 500 mg) or vehicle (VEH) at 2-wk intervals from 124 to 228 d postpartum (DPP). Calves were weaned at 228 DPP. Bovine somatotropin increased (P < .01) milk yield and percentage of milk fat similarly in A, C, and S cows. Calf weaning weight was greater (P < .05) in cows treated with bST than in those given VEH. Administration of bST decreased deposition of fat and increased concentrations of IGF-I, insulin, glucose, and nonesterified fatty acids. In Exp. 2, we compared effects of bST initiated before or after the breeding season. Charolais (n = 33) and S (n = 40) cows were administered (at 2-wk intervals) VEH or bST beginning at 28 DPP (B-bST) or bST beginning at 105 DPP (A-bST). Calves were weaned at 243 DPP. Administration of bST before or after the breeding season increased milk yield on DPP 136 and 194; however, yields were greater in A-bST than in B-bST cows. Milk yields were similar in all cows at 236 DPP, corresponding to decreased forage availability. Calf body weight was greater (P < .05) in A-bST than VEH; B-bST calves were similar to VEH. Fat depth was greater in VEH than in bST-treated cows in C but not in S cows. Serum IGF-I was greater in A- and B-bST than in VEH cows. Mean days from calving to serum progesterone > 1 ng/mL and pregnancy rates were similar in VEH, A-, and B-bST cows. Administration of bST increased cow milk yield and subsequent calf weaning weight when initiated after 100 d postpartum. As anticipated, bST increased IGF-I, insulin, glucose, and nonesterified fatty acids. Administration of bST before and during the breeding season did not affect reproductive performance.
在实验1中,安格斯牛(A,n = 30头)、夏洛莱牛(C,n = 37头)和西门塔尔牛(S,n = 30头)经产母牛于产后124至228天(DPP)每隔2周皮下注射重组牛生长激素(bST;善体保,500毫克)或赋形剂(VEH)。犊牛于228 DPP断奶。bST使A、C和S母牛的产奶量和乳脂百分比均显著增加(P <.01)。bST处理的母牛所产犊牛的断奶体重高于(P <.05)接受VEH处理的母牛。注射bST减少了脂肪沉积,增加了胰岛素样生长因子-I(IGF-I)、胰岛素、葡萄糖和非酯化脂肪酸的浓度。在实验2中,我们比较了在繁殖季节之前或之后开始使用bST的效果。夏洛莱牛(n = 33头)和西门塔尔牛(n = 40头)母牛于28 DPP(B-bST)或105 DPP(A-bST)开始每隔2周注射VEH或bST。犊牛于243 DPP断奶。在繁殖季节之前或之后注射bST可提高第136和194天的产奶量;然而,A-bST母牛的产奶量高于B-bST母牛。在第236天所有母牛的产奶量相似,此时对应着饲料供应量减少。A-bST处理的犊牛体重高于(P <.05)VEH处理的犊牛;B-bST处理的犊牛与VEH处理的犊牛相似。在夏洛莱牛中,VEH处理的母牛脂肪深度大于bST处理的母牛,但西门塔尔牛中并非如此。A-bST和B-bST处理的母牛血清IGF-I高于VEH处理的母牛。VEH、A-bST和B-bST处理的母牛从产犊到血清孕酮>1纳克/毫升的平均天数和妊娠率相似。产后100天后开始注射bST可提高母牛的产奶量和随后犊牛的断奶体重。正如预期的那样,bST增加了IGF-I、胰岛素、葡萄糖和非酯化脂肪酸。在繁殖季节之前和期间注射bST不影响繁殖性能。